Broadcast technology developer Pebble Beach Systems (LON: PEB) will be demonstrating how well its PRIMA platform works with NVIDIA Holoscan for Media at a major industry exhibition in Amsterdam. The backing of NVIDIA for the technology is a positive. The share price improved 19.6% to 13.15p.
Shore Capital has upgraded animal feed additives supplier Anpario (LON: ANP) after it reported 11% higher interim revenues of £17m on the back of a much greater rise in volumes and slightly lower pricing. Raw material costs have stabilised. Full year revenues expectations have been raised from £33m to £34m, while the pre-tax profit estimate is increased from £3.9m to £4.4m, up from £3.5m in 2023. The share price is 13.8% higher at 310p.
Arecor Therapeutics (LON: AREC) is presenting full data from the phase 1 clinical trial of AT278 in type 2 diabetes in Madrid. The data shows that the raid acting insulin treatment maintains its ultra-fast action whatever the type of diabetes or the body mass of the patient. Progress has been hampered by lack of funding and the presentation should raise interest from potential partners. The share price increased 3.23% to 80p.
FALLERS
Chariot (LON: CHAR) says work at a pilot hole to evaluate the Anchois Footwall prospect was abandoned due to it being water bearing. The presence of gas is indicated in the area. Drilling of the main hole has started. Further details are expected next week. Chariot has a 30% interest. The share price dived 44.5% to 3.54p, although it has recovered from its low on the day.
Greatland Gold (LON: GGP) shares returned from suspension after announcing the purchase of Newmont Corporation’s 70% stake in the Havieron gold-copper project, as well as 100% ownership of the Telfer gold-copper mine and other assets in the Paterson region. The total cost is $475m in cash and shares. A placing raised £248.6m ($325m) at 4.8p each, which is a 30% discount to the market price. Wyloo is subscribing up to $100m and Newmont Corporation will own more than 20% of the gold explorer. Individual shareholders have the chance to participate in a retail offer via PrimaryBid to raise up to £6.8m. The share price slipped 21.6% to 5.45p.
Cannabis medicines developer Celadon Pharmaceuticals (LON: CEL) has raised £1.05m at 40p/share. The share price declined 22.9% to 40.5p. Celadon Pharmaceuticals is still talking to the previous equity subscriber that has not provided the funds, where the subscription price was 105p/share. There was £48,000 in the bank before the latest fundraising. There should be enough cash until the end of the year. A strategic collaboration with Valeos Pharma, which will licence some genetics for cultivation from Celadon Pharmaceuticals, which will use its expertise to help to increase yields and quality of cannabis. Celadon Pharmaceuticals will be able to use the crop grown by Valeos to supply its major European customer and generate a margin on the sale. The deal could also generate £1.7m of additional income based on increased yield and pricing.
Vast Resources (LON: VAST) has signed two agreements for the processing and marketing of products from the former Hanes gold mine in Romania. The first is with Explore Eco Mining, which will apply for permits for a processing facility and Vast Resources will receive 20% of the difference between revenues and production costs. The second agreement is with Albamin Industry for the marketing of 500 tonnes of polymetallic concentrate held in a dump. Vast Resources will receive 20% of the revenues and all expenses. The share price fell 12.5% to 0.105p.
AI-based digital advertising services provider Silver Bullet Data Services (LON: SBDS) slipped despite improving results. It has shed low margin work and still managed to grow revenues from £4.2m to £4.4m. Lower overheads meant that the reported loss fell from £1.8m to £1.6m. Management believes that the company can become EBITDA positive in October and this should be sustainable. Total bookings and committed revenues for 2024 have already reached £8.3m. Net debt was £2.6m at the end of June 2024. The share price is 5.23% lower at 72.5p.